Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: Matched case–control and cohort studies
Open Access
- 19 February 2021
- journal article
- research article
- Published by Elsevier BV in Allergology International
- Vol. 70 (3), 335-342
- https://doi.org/10.1016/j.alit.2021.01.004
Abstract
No abstract availableKeywords
Funding Information
- Keio Gijuku Daigaku
This publication has 40 references indexed in Scilit:
- Bayesian regression in SAS softwareInternational Journal of Epidemiology, 2012
- Incidence of Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome in an HIV CohortAmerican Journal of Clinical Dermatology, 2012
- Toxic epidermal necrolysis and Stevens-Johnson syndrome: A review*Critical Care Medicine, 2011
- Bias‐reduced and separation‐proof conditional logistic regression with small or sparse data setsStatistics in Medicine, 2010
- Cross-sensitivity of skin rashes with antiepileptic drug useNeurology, 2008
- Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-StudyJournal of Investigative Dermatology, 2008
- Comparison and predictors of rash associated with 15 antiepileptic drugsNeurology, 2007
- Erythema Multiforme, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in ChildrenDrug Safety, 2002
- Anticonvulsant Hypersensitivity SyndromeDrug Safety, 1999
- Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal NecrolysisThe New England Journal of Medicine, 1995